Skip to main content
Top
Published in: BMC Nephrology 1/2016

Open Access 01-12-2016 | Case report

Pauci Immune crescentic glomerulonephritis in a patient with T-cell lymphoma and argyria

Authors: Tamer Rezk, James Penton, Anna Stevenson, Mared Owen-Casey, Mark Little, John Cunningham, Alan D. Salama

Published in: BMC Nephrology | Issue 1/2016

Login to get access

Abstract

Background

Silver is a transition metal, toxic when ingested in significant amounts, causing argyria (skin deposition) and argyrosis (eye deposition). It is excreted mainly via the gastrointestinal tract with only small amounts eliminated by the kidneys, and rarely have cases of nephrotoxicity due to silver been reported. Here we present the case of a woman who used colloidal silver as an alternative remedy for a T cell lymphoma, who subsequently developed argyria and a pauci-immune crescentic glomerulonephritis with evidence of extensive glomerular basement membrane silver deposition.

Case Presentation

A 47 year old woman of Indo-Asian descent with a T-cell lymphoma who refused conventional chemotherapy for 18 months but self-medicated with a remedy containing colloidal silver, was admitted with acute dialysis-dependent kidney injury. A kidney biopsy demonstrated a pauci-immune crescentic glomerulonephritis with deposition of silver particles in the mesangium and along the glomerular basement membranes. The patient was treated with intravenous methylprednisolone and intravenous cyclophosphamide and recovered independent renal function.

Conclusion

Chronological evolution of the the pauci-immune glomerulonephritis suggests that a cellular immune-mediated process was induced, potentially mediated by lymphomatous T cells directed at the glomerular basement membrane, following silver deposition. Immunosuppressive therapy improved the situation and allowed cessation of haemodialysis, supporting the hypothesis of an immune-mediated process.
Literature
1.
go back to reference East BW, Boddy K, Williams ED, Macintyre D, McLay AL. Silver retention, total body silver and tissue silver concentrations in argyria associated with exposure to an anti-smoking remedy containing silver acetate. Clin Exp Dermatol. 1980;5(3):305–11.CrossRefPubMed East BW, Boddy K, Williams ED, Macintyre D, McLay AL. Silver retention, total body silver and tissue silver concentrations in argyria associated with exposure to an anti-smoking remedy containing silver acetate. Clin Exp Dermatol. 1980;5(3):305–11.CrossRefPubMed
2.
go back to reference Maitre S, Jaber K, Perrot JL, Guy C, Cambazard F. Increased serum and urinary levels of silver during treatment with topical silver sulfadiazine. Ann Dermatol Venereol. 2002;129(2):217–9.PubMed Maitre S, Jaber K, Perrot JL, Guy C, Cambazard F. Increased serum and urinary levels of silver during treatment with topical silver sulfadiazine. Ann Dermatol Venereol. 2002;129(2):217–9.PubMed
3.
go back to reference Owens CJ, Yarbrough 3rd DR, Brackett Jr NC. Nephrotic syndrome following topically applied sulfadiazine silver therapy. Arch Intern Med. 1974;134(2):332–5.CrossRefPubMed Owens CJ, Yarbrough 3rd DR, Brackett Jr NC. Nephrotic syndrome following topically applied sulfadiazine silver therapy. Arch Intern Med. 1974;134(2):332–5.CrossRefPubMed
4.
go back to reference Chaby G, Viseux V, Poulain JF, De Cagny B, Denoeux JP, Lok C. Topical silver sulfadiazine-induced acute renal failure. Ann Dermatol Venereol. 2005;132(11 Pt 1):891–3.CrossRefPubMed Chaby G, Viseux V, Poulain JF, De Cagny B, Denoeux JP, Lok C. Topical silver sulfadiazine-induced acute renal failure. Ann Dermatol Venereol. 2005;132(11 Pt 1):891–3.CrossRefPubMed
5.
go back to reference Watanabe Y, Eguchi A, Kamio M, Yamaguchi K, Ohara M, Mochizuki T. Case of membranous nephropathy associated with argyria. Nihon Jinzo Gakkai Shi. 2005;47(5):547–51.PubMed Watanabe Y, Eguchi A, Kamio M, Yamaguchi K, Ohara M, Mochizuki T. Case of membranous nephropathy associated with argyria. Nihon Jinzo Gakkai Shi. 2005;47(5):547–51.PubMed
6.
go back to reference Mayr M, Kim MJ, Wanner D, Helmut H, Schroeder J, Mihatsch MJ. Argyria and decreased kidney function: are silver compounds toxic to the kidney? Am J Kidney Dis. 2009;53(5):890–4.CrossRefPubMed Mayr M, Kim MJ, Wanner D, Helmut H, Schroeder J, Mihatsch MJ. Argyria and decreased kidney function: are silver compounds toxic to the kidney? Am J Kidney Dis. 2009;53(5):890–4.CrossRefPubMed
7.
go back to reference Rosenman KD, Seixas N, Jacobs I. Potential nephrotoxic effects of exposure to silver. Br J Ind Med. 1987;44(4):267–72.PubMedPubMedCentral Rosenman KD, Seixas N, Jacobs I. Potential nephrotoxic effects of exposure to silver. Br J Ind Med. 1987;44(4):267–72.PubMedPubMedCentral
8.
go back to reference Pifer JW, Friedlander BR, Kintz RT, Stockdale DK. Absence of toxic effects in silver reclamation workers. Scand J Work Environ Health. 1989;15(3):210–21.CrossRefPubMed Pifer JW, Friedlander BR, Kintz RT, Stockdale DK. Absence of toxic effects in silver reclamation workers. Scand J Work Environ Health. 1989;15(3):210–21.CrossRefPubMed
9.
10.
go back to reference Xenocostas A, Jothy S, Collins B, Loertscher R, Levy M. Anti-glomerular basement membrane glomerulonephritis after extracorporeal shock wave lithotripsy. Am J Kidney Dis. 1999;33(1):128–32.CrossRefPubMed Xenocostas A, Jothy S, Collins B, Loertscher R, Levy M. Anti-glomerular basement membrane glomerulonephritis after extracorporeal shock wave lithotripsy. Am J Kidney Dis. 1999;33(1):128–32.CrossRefPubMed
11.
go back to reference Tsuda M, Nakashima Y, Ikeda M, Shimada S, Nomura M, Matsushima T, et al. Intravascular Large B-Cell Lymphoma Complicated by Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis that was Successfully Treated with Rituximab-Containing Chemotherapy. J Clin Exp Hematop. 2015;55(1):39–43.CrossRefPubMed Tsuda M, Nakashima Y, Ikeda M, Shimada S, Nomura M, Matsushima T, et al. Intravascular Large B-Cell Lymphoma Complicated by Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis that was Successfully Treated with Rituximab-Containing Chemotherapy. J Clin Exp Hematop. 2015;55(1):39–43.CrossRefPubMed
12.
go back to reference Hamidou MA, El Kouri D, Audrain M, Grolleau JY. Systemic antineutrophil cytoplasmic antibody vasculitis associated with lymphoid neoplasia. Ann Rheum Dis. 2001;60(3):293–5.CrossRefPubMedPubMedCentral Hamidou MA, El Kouri D, Audrain M, Grolleau JY. Systemic antineutrophil cytoplasmic antibody vasculitis associated with lymphoid neoplasia. Ann Rheum Dis. 2001;60(3):293–5.CrossRefPubMedPubMedCentral
Metadata
Title
Pauci Immune crescentic glomerulonephritis in a patient with T-cell lymphoma and argyria
Authors
Tamer Rezk
James Penton
Anna Stevenson
Mared Owen-Casey
Mark Little
John Cunningham
Alan D. Salama
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2016
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-016-0259-x

Other articles of this Issue 1/2016

BMC Nephrology 1/2016 Go to the issue